UPK2 and urothelial carcinoma: At the metastatic site, IPLC and poorly differentiated urothelial carcinoma might show similar morphologies, which indicated that uroplakin II immunopositivity in metastatic carcinoma with poorly differentiated morphology does not directly lead to the diagnosis of poorly differentiated urothelial carcinoma and the possibility of IPLC should also be considered.